Our previous work uncovered that p70S6K activity is robustly induced by surgery in breast cancer patients and that its inhibition, using PF-4708671, strongly impaired breast cancer local relapse in a mouse model of breast cancer, supporting the possibility that it may be crucial also for breast cancer recurrence in human patients [9,10,24]. This evidence concerns the gene RPS6KB1 and breast carcinoma.